High-throughput docking as a source of novel drug leads
JC Alvarez - Current opinion in chemical biology, 2004 - Elsevier
Receptor-based virtual screening has become a viable source of novel leads in the
pharmaceutical industry. The rapidly growing availability of structural information across …
pharmaceutical industry. The rapidly growing availability of structural information across …
High-throughput docking as a source of novel drug leads
JC Alvarez - Current opinion in chemical biology, 2004 - pubmed.ncbi.nlm.nih.gov
Receptor-based virtual screening has become a viable source of novel leads in the
pharmaceutical industry. The rapidly growing availability of structural information across …
pharmaceutical industry. The rapidly growing availability of structural information across …
High-throughput docking as a source of novel drug leads
JC Alvarez - Current Opinion in Chemical Biology, 2004 - infona.pl
Receptor-based virtual screening has become a viable source of novel leads in the
pharmaceutical industry. The rapidly growing availability of structural information across …
pharmaceutical industry. The rapidly growing availability of structural information across …
High-throughput docking as a source of novel drug leads.
JC Alvarez - Current Opinion in Chemical Biology, 2004 - europepmc.org
Receptor-based virtual screening has become a viable source of novel leads in the
pharmaceutical industry. The rapidly growing availability of structural information across …
pharmaceutical industry. The rapidly growing availability of structural information across …
High-throughput docking as a source of novel drug leads
JC Alvarez - Current Opinion in Chemical Biology, 2004 - infona.pl
Receptor-based virtual screening has become a viable source of novel leads in the
pharmaceutical industry. The rapidly growing availability of structural information across …
pharmaceutical industry. The rapidly growing availability of structural information across …